Table 2.

A brief summary of fabricating CMNDDs in vivo

Cell types	Mediated markers	Applications
Neutrophils	Ly6G, Gr1, CD11b	Tumor [83–86], acute lung inflammation [87], inflamed skeletal muscle and ischemic heart [88]
Macrophages	Dectin-1, CD44	Tumor [89–92], acute lung injury [86, 93]
Monocytes	CD14	Tumor [94]
Red blood cells	No specific markers	Tumor [95, 96], acute lung disease [97], general drug delivering system [98]
Platelets	No specific markers	Thrombosis-associated diseases [99, 100], tumor [101–103]